| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Director | Common Stock | 503,126 | $3,280,382 | $6.52 | 27 Sep 2021 | By ERP Business Holdings, LP |
| C4 Therapeutics, Inc. | Director | Common Stock | 31,681 | $206,560 | $6.52 | 27 Sep 2021 | By Spouse |
| C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23,500 | 15 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | 27 Sep 2021 | 2 | -$92,573 | 4 | Director | 29 Sep 2021, 18:33 |
| CCCC | C4 Therapeutics, Inc. | 22 Sep 2021 | 8 | -$1,646,251 | 4 | Director | 24 Sep 2021, 16:51 |
| CCCC | C4 Therapeutics, Inc. | 17 Sep 2021 | 4 | -$1,059,956 | 4 | Director | 21 Sep 2021, 19:26 |
| CCCC | C4 Therapeutics, Inc. | 14 Sep 2021 | 7 | -$3,984,396 | 4 | Director | 16 Sep 2021, 19:31 |
| CCCC | C4 Therapeutics, Inc. | 10 Sep 2021 | 4 | -$460,985 | 4 | Director | 14 Sep 2021, 16:10 |
| CCCC | C4 Therapeutics, Inc. | 03 Aug 2021 | 1 | -$650,587 | 4 | Director | 05 Aug 2021, 19:35 |
| CCCC | C4 Therapeutics, Inc. | 29 Jul 2021 | 2 | -$701,774 | 4 | Director | 02 Aug 2021, 18:47 |
| CCCC | C4 Therapeutics, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 16:16 |